2021
DOI: 10.1039/d1ob01616d
|View full text |Cite
|
Sign up to set email alerts
|

Transition-metal-catalyzed C–H bond activation/functionalization and annulation of phthalazinones

Abstract: Phthalazinones and their higher congeners are commonly prevalent structural motifs that occur in natural products, bioactive molecules, and pharmaceuticals. In the past few decades transition metal-catalyzed reactions have received an...

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
4
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 11 publications
(4 citation statements)
references
References 54 publications
0
4
0
Order By: Relevance
“…[9][10][11][12][13] Among the numerous nitrogen-containing heterocycles, phthalazinone is a kind of annulated six-membered N-heterocycles and has diverse biological activities. [14][15][16][17][18] Phthalazinone and their derivatives have been widely used in the treatment of a variety of diseases such as diabetes, hepatitis B, asthma, vascular hypertension, arrhythmia, cancers, and are as potent inhibitors of poly(ADP-ribose) polymerase-1 (PARP-1) (Figure 1). [19][20][21][22][23] For example, azelastine, a phthalazinone derivative, is a well-known antiallergic and antiasthmatic drug (sales $0.24 billion in 2008).…”
Section: Introductionmentioning
confidence: 99%
“…[9][10][11][12][13] Among the numerous nitrogen-containing heterocycles, phthalazinone is a kind of annulated six-membered N-heterocycles and has diverse biological activities. [14][15][16][17][18] Phthalazinone and their derivatives have been widely used in the treatment of a variety of diseases such as diabetes, hepatitis B, asthma, vascular hypertension, arrhythmia, cancers, and are as potent inhibitors of poly(ADP-ribose) polymerase-1 (PARP-1) (Figure 1). [19][20][21][22][23] For example, azelastine, a phthalazinone derivative, is a well-known antiallergic and antiasthmatic drug (sales $0.24 billion in 2008).…”
Section: Introductionmentioning
confidence: 99%
“…We chose ethanol with the intention of also exploring the activation of the CÀ H bond in the À CH 2 À group. The activation of the CÀ H bond is well established in the literature and is defined as the β-CÀ H mechanism [23][24][25][26] and in this work we explore the mechanism of breaking the CÀ H bond of ethanol.…”
Section: Introductionmentioning
confidence: 99%
“…10 By embracing this area, transition-metal-cata-lyzed C-H activation, especially in alkylation of 2-arylphthalazine-1,4-diones with different coupling partners, has attracted great interest in recent years. 11 In 2019 and 2022, the two groups of Sakhuja 12 and Yu 13 demonstrated Ru(II)-catalyzed C-H alkylation from 2-arylphthalazine-1,4-diones and sulfoxonium ylides, respectively (Scheme 1a). In 2020, Kim and coworkers 14 reported a Ru(II)-catalyzed C-H alkylation of 2-arylphthalazine-1,4-diones with a range of aldehydes and activated ketones (Scheme 1b).…”
mentioning
confidence: 99%